Italia -
italiano -
Ministero della Salute
biofemalia lavanda vaginale
sakura italia s.r.l. - dispositivi per ginecologia - altri
Italia -
italiano -
Ministero della Salute
sensai ultimate the cream 40ml
kanebo cosmetics italy spa -
Unione Europea -
italiano -
EMA (European Medicines Agency)
enspryng
roche registration gmbh - satralizumab - neuromyelitis optica - immunosoppressori - satralizumab (enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (ist) for the treatment of neuromyelitis optica spectrum disorders (nmosd) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 igg (aqp4-igg) seropositive.